tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Eun Yang, 104 are a BUY (73.24%), 30 are a HOLD (21.13%), 8 are a SELL (5.63%).
Analyst Eun Yang, currently employed at JEFFERIES, carries an average stock price target met ratio of 59.44% that have a potential upside of 33.5% achieved within 287 days.
Eun Yang’s has documented 261 price targets and ratings displayed on 29 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on UTHR, United Therapeutics at 23-Sep-2024.
Analyst best performing recommendations are on CNTA (CENTESSA PHARMACEUTICALS PLC ADR).
The best stock recommendation documented was for BBIO (BRIDGEBIO PHARMA) at 1/27/2021. The price target of $72 was fulfilled within 12 days with a profit of $16.53 (29.8%) receiving and performance score of 24.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$42
$-2.15 (-4.87%)
$42
2 years 24 days ago
(15-Feb-2023)
0/15 (0%)
$-2.18 (-4.93%)
Buy
$42
$-2.15 (-4.87%)
$82
2 years 2 months ago
(11-Jan-2023)
0/4 (0%)
$-2.1 (-4.76%)
Buy
$42
$-2.15 (-4.87%)
$68
2 years 2 months ago
(11-Jan-2023)
0/3 (0%)
$-2.1 (-4.76%)
Hold
$55
2 years 2 months ago
(11-Jan-2023)
0/1 (0%)
$36.77 (201.70%)
Hold
$42
$-2.15 (-4.87%)
$61
2 years 2 months 2 days ago
(09-Jan-2023)
0/2 (0%)
$-1.85 (-4.22%)
Which stock is Eun Yang is most bullish on?
What Year was the first public recommendation made by Eun Yang?
